{
    "id": "3fa2b889-ff04-4db1-b2c8-c0238efe240b",
    "indications": "Adults\n                  \n                  REVATIO is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies (14)]. \n                  \n                     Pediatric Patients (1 to 17 Years Old)\n                  \n                  REVATIO is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise [see Clinical Studies (14)].",
    "contraindications": "• Adults: 20 mg orally three times a day. Dose may be increased based on symptoms and tolerability. ( 2.1 ) • Pediatric patients ( 2.2 ) o ≤ 20 kg: 10 mg three times a day o 20 kg to 45 kg: 20 mg three times a day o > 45 kg: 20 mg three times a day. Dose may be increased based on symptoms and tolerability. • Injection (Adults): 10 mg three times a day administered as an intravenous bolus injection. ( 2.1 )",
    "warningsAndPrecautions": "REVATIO tablets are supplied as white to off-white, film-coated, round tablets containing sildenafil citrate equivalent to the nominally indicated amount of sildenafil as follows:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              REVATIO Tablets\n                           \n                        \n                        \n                           \n                              Package Configuration\n                           \n                           \n                              Strength\n                           \n                           \n                              NDC\n                           \n                           \n                              Engraving on Tablet\n                           \n                        \n                        \n                           \n                              Bottle of 90 Tablets\n                           \n                           \n                              20 mg\n                           \n                           \n                              58151-402-77\n                           \n                           \n                              “RVT 20” on one side and “VLE” on the other side\n                           \n                        \n                     \n                  \n                  Recommended Storage for REVATIO Tablets: Store at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  REVATIO injection is supplied as a clear, colorless, sterile, ready to use solution containing 10 mg sildenafil/12.5 mL (0.8 mg/mL) presented in a single-dose glass vial.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              REVATIO Injection\n                           \n                        \n                        \n                           \n                              Package Configuration\n                           \n                           \n                              Strength \n                           \n                           \n                              NDC\n                           \n                        \n                        \n                           \n                              Vial individually packaged in a carton\n                           \n                           \n                              10 mg/12.5 mL (0.8 mg/mL)\n                           \n                           \n                              58151-395-31\n                           \n                        \n                     \n                  \n                  Recommended Storage for REVATIO Injection: Store at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Discard unused portion.\n                  REVATIO powder for oral suspension is supplied in amber glass bottles. Each bottle contains white to slight pink powder containing 1.57 g of sildenafil citrate (equivalent to 1.12 g sildenafil). Following reconstitution, the total volume of the oral suspension is 112 mL (10 mg sildenafil/mL). A 2 mL oral dosing syringe (with 1 mL and 2 mL dose markings) and a press-in bottle adaptor are also provided.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              REVATIO Powder for Oral Suspension\n                           \n                        \n                        \n                           \n                              Package Configuration\n                           \n                           \n                              Strength \n                           \n                           \n                              NDC\n                           \n                        \n                        \n                           \n                              Powder for oral suspension - bottle\n                           \n                           \n                              10 mg/mL (when reconstituted)\n                           \n                           \n                              58151-385-35\n                           \n                        \n                     \n                  \n                  Recommended Storage for REVATIO for Oral Suspension: Store below 30°C (86°F) in the original package in order to protect from moisture.\n                  Recommended Storage for Reconstituted Oral Suspension: Store below 30°C (86°F) or in refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. The shelf-life of the reconstituted oral suspension is 60 days. Any remaining oral suspension should be discarded 60 days after reconstitution.",
    "adverseReactions": "REVATIO is contraindicated in patients with:\n                  \n                     \n                        •Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see \n                        \n                           Warnings and Precautions (5.1)\n                        \n                        ].\n                     \n                        •Concomitant use of riociguat, a guanylate cyclase stimulator. Phosphodiesterase-5 (PDE-5) inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat.\n                     \n                        •Known hypersensitivity to sildenafil or any component of the tablet, injection, or oral suspension. Hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil.",
    "ingredients": [
        {
            "name": "SILDENAFIL CITRATE",
            "code": "BW9B0ZE037"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "DEXTROSE, UNSPECIFIED FORM",
            "code": "IY9XDZ35W2"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        }
    ],
    "organization": "Viatris Specialty LLC",
    "name": "Revatio",
    "effectiveTime": "20241218"
}